by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersPLZ Corp

All Warning Letters

PLZ Corp

Warning LetterOpen

6080 Vipond Dr. Mississauga ON L5T 2V4 CanadaFEI 3001956890Issued Jun 2, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3001956890.

Violations4

Issue DateJun 2, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: PLZ Corp
Location: 6080 Vipond Dr. Mississauga ON L5T 2V4 Canada
FEI Number: 3001956890
Country: Canada
Issue Date: June 02, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/OTC Finished Pharmaceuticals/Adulterated

PLZ Corp FDA Warning Letter, June 2, 2026